{
  "ptid_time": "035_S_0555_2016-06-01",
  "img_path": "/data/qiuhui/data/adni/images/035_S_0555/2016-06-01/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 7,491 mm³, 7.5% above the reference mean. With a Z-score of 0.65 (74.2th percentile), this represents normal volume ; whole brain volume measures 1,133,530 mm³, 10.1% above the reference mean. With a Z-score of 1.33 (90.8th percentile), this represents mild enlargement; entorhinal cortex volume measures 3,043 mm³, 23.3% below the reference mean. With a Z-score of -1.53 (6.3th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,695 mm³, 7.6% below the reference mean. With a Z-score of -0.66 (25.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,359 mm³, 5.9% above the reference mean. With a Z-score of 0.53 (70.1th percentile), this represents normal volume . ",
  "text_data": "Age is 86.0 years. Gender is Male. Education: 16 years. MMSE: 23.0. MoCA: 20.0. Logical Memory: 12.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.35 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The entorhinal cortex shows moderate atrophy (Z-score -1.53, 6.3th percentile), which is a strong biomarker for early Alzheimer's pathology. Hippocampal and whole brain volumes are normal or enlarged, but cognitive scores (MMSE 23, MoCA 20) are below expected thresholds for age, suggesting cognitive impairment. Elevated AV45 (amyloid PET) and APOE4 positivity further support Alzheimer's-related changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer's pathology)  \n**Confidence:** **High** (due to clear entorhinal atrophy, amyloid positivity, and cognitive decline, despite preserved hippocampal volume).",
  "timestamp": "2025-07-26T05:48:48.030845"
}